These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6235247)

  • 1. Stability and blanching potential of corticosteroid ointments.
    Kirsch ; Gibson JR
    J Clin Hosp Pharm; 1984 Jun; 9(2):143. PubMed ID: 6235247
    [No Abstract]   [Full Text] [Related]  

  • 2. Betamethasone dipropionate (0.05)% plus chinoform (3%) cream against betamethasone valerate (0.1%) plus chinoform cream (3%) in secondarily infected dermatoses.
    Chattopadhyay SP; Arora PN; Anand S; Sharma SD
    Indian J Dermatol; 1987 Jul; 32(3):73-6. PubMed ID: 2973437
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical study on the therapeutic activity of a betamethasone dipropionate - iodochloroxyquinoline combination for topical use].
    Sartoris S; Paggio A; De Santolo GP
    G Ital Dermatol Venereol; 1983; 118(6):LI-LIV. PubMed ID: 6232210
    [No Abstract]   [Full Text] [Related]  

  • 4. Potency ranking of two new topical corticosteroid creams containing 0.1% desonide or 0.05% halometasone utilising the human skin blanching assay.
    Meyer E; Smith EW; Haigh JM; Kanfer I
    Arzneimittelforschung; 1988 Dec; 38(12):1840-3. PubMed ID: 3245859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hydrocortisone butyrate (Locoid) compared with betamethasone valerate. A controlled clinical trail].
    Thormann J
    Ugeskr Laeger; 1976 Jan; 138(4):214-6. PubMed ID: 766347
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical evolution with a polyvalent topical compound].
    Soto Melo J; Casado Jiménez M
    Actas Dermosifiliogr; 1979; 70(5-6):407-14. PubMed ID: 158293
    [No Abstract]   [Full Text] [Related]  

  • 7. Norwegian scabies following topical corticosteroid therapy.
    Lipitz R; Tur E; Brenner S; Krakowski A
    Isr J Med Sci; 1981 Dec; 17(12):1165-8. PubMed ID: 7327916
    [No Abstract]   [Full Text] [Related]  

  • 8. Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo.
    Serup J; Holm P
    Dermatologica; 1985; 170(4):189-94. PubMed ID: 3888708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of systemic adverse effects after prolonged local therapy with betamethasone-17-valerate ointment].
    Halsos AM
    Tidsskr Nor Laegeforen; 1978 Feb; 98(4):199-200. PubMed ID: 625746
    [No Abstract]   [Full Text] [Related]  

  • 10. [Systemic effects of externally applied steroid preparations].
    Shimao S; Aso M
    Nihon Rinsho; 1978 May; Suppl():2398-9. PubMed ID: 691776
    [No Abstract]   [Full Text] [Related]  

  • 11. [Testing the loss of efficacy (tachyphylaxis) during external steroid application].
    Koch EM; Jurgovsky E
    Hautarzt; 1985 Mar; 36(3):146-9. PubMed ID: 3997512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A new treatment for vitiligo: topical Kandil therapy combined with oral P.A.B.A].
    Pozo Carballido JL
    Actas Dermosifiliogr; 1978; 69(11-12):369-74. PubMed ID: 380273
    [No Abstract]   [Full Text] [Related]  

  • 13. The treatment of psoriasis with 0.1% domoprednate (a D-homocorticosteroid) and 0.1% betamethasone valerate ointment. A double-blind, randomized trial.
    Christiansen JV; Foged E; Holm P; Jørgensen AS; Reymann F
    Dermatologica; 1985; 170(4):195-8. PubMed ID: 3888709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sicorten: a synthetic corticosteroid for topical treatment of common dermatoses.
    Majerus JP; Reiffers-Mettelock J
    J Int Med Res; 1986; 14(1):46-9. PubMed ID: 2937673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of betamethasone dipropionate (0.05%) and betamethasone valerate (0.1%) ointments in psoriasis and other dermatoses--a multicentric double-blind clinical study.
    Sharma SD
    Indian J Dermatol; 1986; 31(2-3):34-7. PubMed ID: 3327820
    [No Abstract]   [Full Text] [Related]  

  • 16. Blanching activities of betamethasone formulations. The effect of dosage form on topical drug availability.
    Smith EW; Meyer E; Haigh JM
    Arzneimittelforschung; 1990 May; 40(5):618-21. PubMed ID: 2383308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gross hematuria of newborns and infants induced by quinone and 8-quinolinol (Mexaform).
    Bajoghli M
    Eur J Pediatr; 1982 Jul; 138(4):359-60. PubMed ID: 6215253
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative studies on Bi-Nerisona cream (diflucortolone valerinate + chlorquinaldol) and on a combination preparation (betamethasone valerinate + gentamicin + tolnaftate + clioquinol) in a double-blind trial].
    Hernández MS
    Z Hautkr; 1978 Jul; 53(13):453-8. PubMed ID: 150142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical corticosteroid allergy in an urban Australian centre.
    Keegel T; Saunders H; Milne R; Sajjachareonpong P; Fletcher A; Nixon R
    Contact Dermatitis; 2004 Jan; 50(1):6-14. PubMed ID: 15059096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The stability and blanching efficacy of betamethasone-17-valerate in emulsifying ointment.
    Ryatt KS; Feather JW; Mehta A; Dawson JB; Cotterill JA; Swallow R
    Br J Dermatol; 1982 Jul; 107(1):71-6. PubMed ID: 7104209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.